Company Quick10K Filing
GB Sciences
10-K 2021-03-31 Filed 2021-07-06
10-Q 2020-12-31 Filed 2021-02-16
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-09-02
10-K 2020-03-31 Filed 2020-08-28
10-Q 2019-12-31 Filed 2020-02-18
10-Q 2019-09-30 Filed 2019-11-15
10-Q 2019-06-30 Filed 2019-08-15
S-1 2019-05-03 Public Filing
10-K 2019-03-31 Filed 2019-07-15
S-1 2019-03-12 Public Filing
10-Q 2018-12-31 Filed 2019-02-19
10-Q 2018-09-30 Filed 2018-11-14
S-1 2018-09-20 Public Filing
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-29
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-07-12
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-07-14
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-18
10-K 2015-03-31 Filed 2015-06-29
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-27
10-Q 2013-10-01 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-19
10-K 2013-03-31 Filed 2013-07-15
10-Q 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-12-13
10-Q 2012-06-30 Filed 2012-08-20
10-K 2012-03-31 Filed 2012-07-16
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-22
10-K 2011-03-31 Filed 2011-07-11
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-07-14
10-Q 2009-12-31 Filed 2010-02-22
8-K 2020-12-16
8-K 2020-11-23
8-K 2020-11-20
8-K 2020-10-15
8-K 2020-10-14
8-K 2020-10-14
8-K 2020-08-18
8-K 2020-06-29
8-K 2020-05-12
8-K 2020-04-23
8-K 2020-04-09
8-K 2020-03-24
8-K 2019-11-27
8-K 2019-11-19
8-K 2019-11-07
8-K 2019-10-23
8-K 2019-09-12
8-K 2019-09-01
8-K 2019-08-15
8-K 2019-08-10
8-K 2019-07-26
8-K 2019-06-17
8-K 2018-09-21
8-K 2018-09-21
8-K 2018-04-06
8-K 2018-03-07
8-K 2018-02-23

GB Sciences Financials

GBLX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Cash90018003,2131,6382820345671782,0729911,4559711,4873,5804,65932422885
Accounts Receivable150501069686868248553667907430488187
Inventory32735336071,0491,4132,8332,1371,542
PP&E3636363600781456999831,5871,8953,2286,8257,6848,60511,29611,73215,22316,25023,11925,86810,265
Assets6349424225533,3122,0131,5861,4512,2842,3373,5609,3239,12311,85515,16016,39724,05028,26230,63530,02329,840
Accounts Payable0423111134212446771,0961,1517631481264576933722982,2703,0711,621
Long-Term Debt2,0202,0954731355314225521521
Liabilities1,7311,7519648741,2569631,144616-55411,2052,8413,5804,2237,2405,4824,4307,4957,9218,4188,37411,26412,86715,525
Stockholders' Equity-1,669-1,702-922-832-1,232-958-1,1412,6962,0181,148246-557-1,244-6162,0733,5847,3167,5358,47612,74913,38910,3308,3005,288
Income Statement ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Revenue00000000000000541371,2758751,3156967261,172
Cost of Revenue0000000003882255813032,0601,857
Gross Profit000000000887650735393-1,334-685
R&D
SG&A221818614135621,780678-11,9272,6931,1291,2082,1983,2152,8752,7797,1076,7754,4642,9833,7871,403
Tax738-211-57
Net Income-75-34-3190274-183-1,445-1,670-622-3,986-2,681-1,097-1,341-2,467-3,524-3,082-3,145-6,962-9,779-5,167-3,763-4,983-2,683
Cash Flow ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Cash Operating-9-11-5-939-1,507-869-231-958-735-1,148-2,190-3,061-2,771-4,225-3,496-1,708
Cash Investing000-29-69-557-8-892-87-1,024-138-510-829-3,927-2,662-1,138
Cash Financing01153,842071-441,9942,7161,0911,0903,0884,11610,2457,2372,749